Kristina Jankovic/X
Apr 12, 2025, 06:13
Kristina Jankovic: KRISTINE study design – Neoadjuvant therapy in HER2+ early Breast Cancer
Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared a post on X:
“They say not to take trials personally…
But when it’s called KRISTINE you pay extra attention….
Neoadjuvant therapy in HER2+ early Breast Cancer:
- TCH+P leads to higher pCR.
- T-DM1+P leads to better tolerability.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 19:36
Apr 19, 2025, 19:17
Apr 19, 2025, 19:01
Apr 19, 2025, 18:42
Apr 19, 2025, 18:29
Apr 19, 2025, 17:53
Apr 19, 2025, 17:17